GSTM1 and myeloproliferative disorder: The analysis of the clinical parameters in this study included the mean hemoglobin (Hb) level (g/L), white blood cell (WBC) count (×109/L), and platelet (Plt) count (×109/L), according to MPN phenotypes, as shown in Table 2.